Rather than using the standard 0.25 to 0.5 mg daily dose, micro-dosing protocols employ significantly smaller amounts, typically ranging from 0.1 to 0.15 mg per administration
hold a published patent (WO/2023/180570) that covers the in vitro method for identifying anti-senescence compounds based on detecting the binding of said compound in the presence of at least one phosphorylated amino acid in the transcription activation domain (TAD) domain of mammalian protein p53
Joint pain, slow recovery, gut issues, low energy...these are things clinicians at Midi hear about from women every day, and they deserve real answers
Product purity
Not everyone needs every peptide, and staggered implementation helps identify the minimum effective stack
These are symptoms of pernicious anemia, which occurs when the body doesnt have enough vitamin B12 to support healthy red blood cell production (NIH-b, 2021)